ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

140
Analysis
Health CareIndia
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
08 Jan 2021 13:27

Asia HY Monthly - 2020 In Review And 2021 Outlook - Lucror Analytics

This month, we review the developments of 2020, an extraordinary year from an investor’s perspective, and give our outlook for the year ahead.  ...

Logo
98 Views
Share
23 Dec 2020 17:46

Asia HY Trade Book - December 2020 - Lucror Analytics

The Asia HY Trade Book for the month of December includes a summary of our recommendations, as well as our high-conviction ideas. The report also...

Logo
87 Views
Share
02 Dec 2020 16:10

Asia HY Monthly - Macau Gaming Update - Lucror Analytics

In this month’s “In-Focus” section, we provide an update on the Macau gaming sector, including our market outlook, concession renewals and a peer...

Logo
60 Views
Share
30 Nov 2020 15:50

Asia HY Trade Book - November 2020 - Lucror Analytics

The Asia HY Trade Book for the month of November includes a summary of our recommendations, as well as our high-conviction ideas. The report also...

Logo
67 Views
Share
25 Nov 2020 08:59

Morning Views Asia: Glenmark Pharmaceuticals, Lifestyle International Holdings, Tunas Baru Lampung

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
177 Views
Share
x